Cargando…
Use of psychiatric drugs in Dermatology()()
Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175395/ https://www.ncbi.nlm.nih.gov/pubmed/32171543 http://dx.doi.org/10.1016/j.abd.2019.12.002 |
_version_ | 1783524825992527872 |
---|---|
author | Weber, Magda Blessmann Recuero, Júlia Kanaan Almeida, Camila Saraiva |
author_facet | Weber, Magda Blessmann Recuero, Júlia Kanaan Almeida, Camila Saraiva |
author_sort | Weber, Magda Blessmann |
collection | PubMed |
description | Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the most suitable treatment rapidly. It is important for dermatologists to be familiar with the most commonly used drugs for the best management of psychiatric symptoms associated with dermatoses, as well as to manage dermatologic symptoms triggered by psychiatric disorders. |
format | Online Article Text |
id | pubmed-7175395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-71753952020-04-22 Use of psychiatric drugs in Dermatology()() Weber, Magda Blessmann Recuero, Júlia Kanaan Almeida, Camila Saraiva An Bras Dermatol Continuing Medical Education Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the most suitable treatment rapidly. It is important for dermatologists to be familiar with the most commonly used drugs for the best management of psychiatric symptoms associated with dermatoses, as well as to manage dermatologic symptoms triggered by psychiatric disorders. Sociedade Brasileira de Dermatologia 2020 2020-02-18 /pmc/articles/PMC7175395/ /pubmed/32171543 http://dx.doi.org/10.1016/j.abd.2019.12.002 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Continuing Medical Education Weber, Magda Blessmann Recuero, Júlia Kanaan Almeida, Camila Saraiva Use of psychiatric drugs in Dermatology()() |
title | Use of psychiatric drugs in Dermatology()() |
title_full | Use of psychiatric drugs in Dermatology()() |
title_fullStr | Use of psychiatric drugs in Dermatology()() |
title_full_unstemmed | Use of psychiatric drugs in Dermatology()() |
title_short | Use of psychiatric drugs in Dermatology()() |
title_sort | use of psychiatric drugs in dermatology()() |
topic | Continuing Medical Education |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175395/ https://www.ncbi.nlm.nih.gov/pubmed/32171543 http://dx.doi.org/10.1016/j.abd.2019.12.002 |
work_keys_str_mv | AT webermagdablessmann useofpsychiatricdrugsindermatology AT recuerojuliakanaan useofpsychiatricdrugsindermatology AT almeidacamilasaraiva useofpsychiatricdrugsindermatology |